Exploring how certain antimicrobial peptides can fight antibiotic-resistant bacteria.
Investigating beta-hairpin antimicrobial peptide membrane activity and toxicity.
This study is exploring special proteins that can fight off tough bacteria that don't respond to regular antibiotics, with the hope of finding new and better treatments for infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri Kansas City NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10785418 on NIH RePORTER |
What this research studies
This research focuses on understanding the structure and function of β-hairpin antimicrobial peptides, which are promising candidates for combating antibiotic-resistant pathogens. The project aims to develop new strategies for antibiotic discovery by investigating how these peptides can penetrate bacterial membranes and disrupt their function. By utilizing a novel synthetic peptide screening technique, the research will analyze thousands of synthetic β-AMPs to determine their antibacterial potency and toxicity to mammalian cells. This could lead to the development of more effective treatments for bacterial infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from bacterial infections that are resistant to current antibiotic treatments.
Not a fit: Patients with non-bacterial infections or those who do not have antibiotic-resistant infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that are effective against resistant bacterial infections.
How similar studies have performed: Other research has shown promise in using antimicrobial peptides to combat bacterial resistance, indicating that this approach has potential for success.
Where this research is happening
Kansas City, United States
- University of Missouri Kansas City — Kansas City, United States (Active)
Researchers
- Principal investigator: Randall, Justin Roy — University of Missouri Kansas City
- Study coordinator: Randall, Justin Roy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.